seed
Stage
1
Investors
About
Vitruviae develops proprietary immunotherapies targeting sugars and lipids uniquely expressed on cancer cells and cancer stem cells, aiming to improve the efficacy and safety of treatments for acute myeloid leukemia and solid tumors.
Explore Vitruviae's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.